 |
|
Is Public Health Ready for Genetics?
Arch Pediatr Adolesc Med. 2001;155:117-118.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
NEWBORNS ARE screened for phenylketonuria (PKU), congenital hypothyroidism,
and sickle cell anemia because treatment is effective if started before symptoms
and signs lead to clinical diagnosis. For most of the other disorders for
which newborns are screened in most states, treatment is thought to be effective,
although evidence has been difficult to collect.1
It comes as a surprise, therefore, that in 19 states, the "follow-up
coordinators" of these public health programs (or their designees) thought
that children identified by newborn screening might be "unsuitable choices
for future reproduction" and that conveying this information should be one
of the goals of counseling parents.2 It is
true that young women who have been successfully treated for PKU, but who
no longer follow the low-phenylalanine diet prior to becoming pregnant, will
give birth to impaired infants (maternal PKU). Continuing on the special diet
or resuming it periconceptionally can prevent or greatly diminish the . . . [Full Text of this Article]
RELATED ARTICLE
Genetic Counseling and Risk Communication Services of Newborn Screening Programs
Michael H. Farrell, Laura K. Certain, and Philip M. Farrell
Arch Pediatr Adolesc Med. 2001;155(2):120-126.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Ethical issues in predictive genetic testing: a public health perspective.
Fulda and Lykens
J. Med. Ethics 2006;32:143-147.
ABSTRACT
| FULL TEXT
Is Public Health Ready for Genetics? An Unanswered Question
Cunningham et al.
Arch Pediatr Adolesc Med 2001;155:1175-1176.
FULL TEXT
|
